Acumen Pharmaceuticals, Inc. ($ABOS)
Filing Information
| Accession Number | 0001628280-26-001265 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 8, 2026 |
| Document Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
14,905
Total Value
$29,436.03
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CFO & Chief Business Officer | Common Stock | โ | Jan 5, 2026 | Sale | 4,000 | $1.96 | $7,842.40 | 227,744 | Direct | โ | View Details | |
CFO & Chief Business Officer | Common Stock | โ | Jan 6, 2026 | Sale | 5,100 | $1.97 | $10,027.62 | 222,644 | Direct | โ | View Details | |
CFO & Chief Business Officer | Common Stock | โ | Jan 7, 2026 | Sale | 4,105 | $2.00 | $8,189.48 | 218,539 | Direct | โ | View Details | |
CFO & Chief Business Officer | Common Stock | โ | Jan 7, 2026 | Sale | 1,700 | $1.99 | $3,376.54 | 216,839 | Direct | โ | View Details |